DIVISLABNSEDivi's Laboratories Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 5 Sept, 2025 · 14:22 IST

Divi's Laboratories Limited has informed the Exchange about change in Management

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.8%Reaction day
₹6130.00
prior close
₹6037.50
announcement price
In-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.0%-1.8% vs market
Pharmaceuticals peers, median of 151sector+0.2%-2.0% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty 100 and 2.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
-0.1
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.8+0.0-1.8+0.2-2.0
Next day
-1.6+0.2-1.8+0.1-1.7
2d
-2.0+0.5-2.6+0.2-2.2
3d
-1.6+1.0-2.6+0.3-2.0
4d
-1.7+1.1-2.8+0.7-2.5
5d
-1.8+1.5-3.3+0.7-2.5
1w
-0.7+2.2-2.9+1.4-2.2
15d
-7.4-0.3-7.2-2.7-4.8
1m
-5.1+1.5-6.6-1.5-3.6
2m
+12.2+3.2+9.0-3.7+15.9
3m
+5.8+5.3+0.5-7.2+13.0
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Divi's Laboratories Limited has informed the stock exchange about a change in its management. The filing, sourced from NSE, does not specify the nature of the change, the role involved, or the name of the person affected. No additional details such as whether it is a resignation, appointment, or internal reshuffle have been disclosed in the headline provided. Shareholders would need to refer to the full filing or the company's detailed disclosure for specifics on the identity and direction of the change.

Likely market impact

Without further details on who is leaving or joining and the strategic implications, investors should treat this as a wait-and-watch event until more information is shared by the company.